Skip to main content
SpringerLink
Log in

Systemische Therapie zerebraler Metastasen beim Mammakarzinom

  • Conference paper
ZNS-Metastasierung des Mammakarzinoms

  • 20 Accesses

Zusammenfassung

Über das Behandlungskonzept zerebraler Metastasen bei Patientinnen mit Mammakarzinom besteht derzeit noch kein Konsens, obwohl die Strahlentherapie als Standardtherapie angesehen wird. Dies hat mehrere Gründe. Erstens liegen randomisierte Studien über die Wertigkeit der Chemotherapie, Strahlentherapie und Chirurgie nicht vor. Zweitens wurde der Chemotherapie zerebraler Metastasen beim Mammakarzinom erst in jüngster Zeit größere Aufmerksamkeit geschenkt. Und drittens ist die Prognose dieser Patientinnen sehr unterschiedlich, da Gehirnmetastasen früh, aber auch spät im Verlauf der Dissemination auftreten können.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

Literatur

  1. Borgelt B, Gelber R, Larson M, Hendrickson F, Griffin T, Roth R (1981) Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the radiation therapy oneology group. Rad Oncol Biol Phys 7: 1633–1638

    Article  CAS  Google Scholar 

  2. Carey RW, Davis JM, Zervas NT (1981) Tamoxifen-induced regression of cerebral metastases in breast Carcinoma. Cancer Treat Rep 65: 793–795

    PubMed  CAS  Google Scholar 

  3. Casimir M, DiStefano A, Hortobagyi GN, Blumenschein GR (1981) The influence of combined modality treatment on the survival of breast cancer patients with brain metastases. Proc Am Soc Clin Oncol 22: 442

    Google Scholar 

  4. Falk W, Halama JM, Halama J (1985) Radioonkologische Überlegungen zur Therapie von Hirnmetastasen anhand von 140 eigenen Fällen. Strahlentherapie 161 (1): 13–22

    PubMed  CAS  Google Scholar 

  5. Ginsberg S, Kirshner J, Reich S (1981) Systemic chemotherapy for a primary germ cell tumor of the brain: a pharmacokinetic study. Cancer Treat Rep 65: 477–483

    PubMed  CAS  Google Scholar 

  6. Glass JP, Foley KM (1987) Brain metastases in patients with breast cancer. In: Harris JR, Hellman S, Henderson IC, Kinne DW (eds). Breast diseases. Lippincott, Philadelphia, pp 480–488

    Google Scholar 

  7. Grisoli F, Vincentelli F, Foa J (1981) Effects of bromocriptine on brain metastasis in breast cancer. Lancet II: 745

    Google Scholar 

  8. Hansen SB, Galsgärd H, Eyben FE von, Westergaard-Nielsen V, Wolf-Jensen J (1986) Tamoxifen for brain metastases from breast cancer. Ann Neurol 20: 544

    Article  PubMed  CAS  Google Scholar 

  9. Hasegawa H, Shapiro WR, Posner JB, Basler G (1979) Effect of l-(4-Amino-2-methyl- 5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride on experimental brain tumors. Cancer Res 39: 2687–2690

    PubMed  CAS  Google Scholar 

  10. Hasegawa H, Ushio Y, Hayakawa T, Yamada K, Mogami H (1983) Changes in the blood-brain barrier transport in experimental metastatic brain tumors. J Neurosurg 59: 304

    Article  PubMed  CAS  Google Scholar 

  11. Heiss WD, Kroiss A, Kühböck J, Profanter W (1974) Kombinierte zytostatische Therapie maligner Hirntumoren. MMW 116: 1957–1960

    CAS  Google Scholar 

  12. Hidalgo V, Dy C, Hidalgo OF, Calvo A (1987) Simultaneous radiotherapy and cisplatinum for the treatment of brain metastases. J Clin Oncol 10: 205–209

    Article  CAS  Google Scholar 

  13. Hildebrand J, Brihaye J, Wagenknecht L, Michel J, Kenis Y (1975) Combination chemotherapy with CCNU, vincristine and methotrexate in primary and metastatic brain tumors. Eur J Cancer 11: 585–587

    Article  PubMed  CAS  Google Scholar 

  14. Hug V, Hort G (1988) Mitromycin for treatment of brain parenchymal disease. J Clin Oncol 6: 1787

    PubMed  CAS  Google Scholar 

  15. Johnson BE, Becker B, Goff WB (1985) Neurologie, neuropsychologic, and computed cranial tomography scan abnormalities in 2- to 10-year survivors of small-eell lung cancer. J Clin Oncol 3: 1659–1667

    PubMed  CAS  Google Scholar 

  16. Keim H, Potthoff RC, Neiss A (1984) Behandlungsergebnisse bei Hirnmetastasen mit primärer Bestrahlung und nach Operation und Nachbestrahlung. Strahlentherapie 160: 309–317

    PubMed  CAS  Google Scholar 

  17. Krauseneck P (1980) Chemotherapie von Hirnmetastasen. In: v. Heyden HW, Krauseneck P (Hrsg) Aktuelle Onkologie, Bdl 3. Zuckschwerdt, München S167–179

    Google Scholar 

  18. Levin VL (1975) A pharmacologic basis for brain tumor chemotherapy. Semin Oncol 2: 57–63

    PubMed  CAS  Google Scholar 

  19. Levin VA, Ausman J, Chadwick M (1972) Pharmacokinetics of Standard molecules and chemotherapeutic agents in a murine glioma. Proc Am Assoc Cancer Res 13: 95

    Google Scholar 

  20. Mende S, Bleichner F, Stoeter P, Meuret G (1983) Erfolgreiche Behandlung von Hirnmetastasen bei Mammakarzinom mit nicht liquorgängigen Zytostatika und Hormonen. Onkologie 6: 58–61

    Article  PubMed  CAS  Google Scholar 

  21. Pouillart P, Mathe G, Palangie T et al. (1977) Treatment of malignant gliomas and brain metastases in adults using a combination of adriamyeine, VM 26, and CCNU results of a type II trial. In: Tactics and strategy in cancer treatment. Springer, Berlin Heidelberg New York, pp 17–28

    Google Scholar 

  22. Postmus PE, Holthuis JIM, Haaxma-Reiche H (1984) Penetration of VP 16-213 into cerebrospinal fluid after high-dose intravenous administration. J Clin Oncol 2: 215–220

    PubMed  CAS  Google Scholar 

  23. Postmus PE, Haaxma-Reiche H, Perendsen HH, Sleijfer DT (1989) High-dose etoposide for meningeal carcinomatosis in patients with small cell lung cancer. Eur J Cancer Clin Oncol 25: 377–378

    Article  PubMed  CAS  Google Scholar 

  24. Przuntek H (1983) Blut-Hirn-Schranken-Permeabilität und Rezeptorafflnität von Zytostatika. In: v. Heyden HW, Krauseneck P (Hrsg) Aktuelle Onkologie, Bd 13. Zuckschwerdt, München, S 24–30

    Google Scholar 

  25. Rapoport SI (1976) Blood-brain barrier in physiology and medicine. Raven Press, New York, p 1

    Google Scholar 

  26. Robustelli della Cuna G, Pavesi L, Knerich R, Preti P, Paoletti P (1984) Radio-chemoimmunotherapy ( CCNU plus levamisole) for treatment of metastatie brain tumors. J Neurooncol 2: 237–240

    Google Scholar 

  27. Rosner D, Nemoto T, Lane WW (1986) Chemotherapy induces regression of brain metastases in breast Carcinoma. Cancer 58: 832–839

    Article  PubMed  CAS  Google Scholar 

  28. Sage MR (1982) Blood-brain barrier: Phenomenon of increasing importance to the imaging clinician. AJNR 3: 127–138

    Google Scholar 

  29. Shapiro WR (1980) Chemotherapy of metastatie central nervous system Carcinoma. In: Weiss L, Gilbert HA, Posner JB (eds) Brain metastasis. Hall, Boston, pp 27–35

    Google Scholar 

  30. Sparrow GEA, Rubens RD (1981) Brain metastases from cancer: clinical course, prognosis and influence of treatment. Clin Oncol 7: 291–301

    PubMed  CAS  Google Scholar 

  31. Stewart DJ, Leavens M, Maor M (1982) Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors. Cancer Res 42: 2474–2479

    PubMed  CAS  Google Scholar 

  32. Takakura K, Sano K, Hojo A, Hirano A (1982) Metastatie tumors of the central nervous system. Igaku-Shoin, Tokyo, pp 195–279

    Google Scholar 

  33. Ushio Y, Posner JB, Shapiro WR (1977) Chemotherapy of experimental meningeal carcinomatosis. Cancer Res 37: 1232–1237

    PubMed  CAS  Google Scholar 

  34. Vick NA, Khandekar JD, Bigner DD (1977) Chemotherapy of brain tumors. The “blood-brain barrier” is not a factor. Arch Neurol 34: 523–526

    Google Scholar 

  35. Wilson WL, de la Garza JG (1965) Systemic chemotherapy for CNS metastases of solid tumors. Arch Intern Med 115: 710–713

    CAS  Google Scholar 

Download references

Authors
  1. E. D. Kreuser
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Schuster
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Thiel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik und Poliklinik, Klinikum Rudolf Virchow der Freien Universität Berlin, Spandauer Damm 130, W-1000, Berlin 19, Bundesrepublik Deutschland

    Richard Herrmann

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Kreuser, E.D., Schuster, C., Thiel, E. (1991). Systemische Therapie zerebraler Metastasen beim Mammakarzinom. In: Herrmann, R. (eds) ZNS-Metastasierung des Mammakarzinoms. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76359-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76359-5_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-53575-1

  • Online ISBN: 978-3-642-76359-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation